162 related articles for article (PubMed ID: 11055270)
1. Hepatotoxicity of acetaminophen and N-acetyl-p-benzoquinone imine and enhancement by fructose.
Hojo M; Hanioka K; Miyata M; Yamazoe Y
Xenobiotica; 2000 Sep; 30(9):933-41. PubMed ID: 11055270
[TBL] [Abstract][Full Text] [Related]
2. Selective mitochondrial glutathione depletion by ethanol enhances acetaminophen toxicity in rat liver.
Zhao P; Kalhorn TF; Slattery JT
Hepatology; 2002 Aug; 36(2):326-35. PubMed ID: 12143040
[TBL] [Abstract][Full Text] [Related]
3. Role of NAD(P)H:quinone oxidoreductase 1 in clofibrate-mediated hepatoprotection from acetaminophen.
Moffit JS; Aleksunes LM; Kardas MJ; Slitt AL; Klaassen CD; Manautou JE
Toxicology; 2007 Feb; 230(2-3):197-206. PubMed ID: 17188792
[TBL] [Abstract][Full Text] [Related]
4. Effects of fructose-induced hypertriglyceridemia on hepatorenal toxicity of acetaminophen in rats. II. Role of enhancement of fructose metabolism and overproduction of triglyceride in the liver and kidney on hepatorenal toxicity of acetaminophen.
Ishida K; Sakazume M; Hirai N; Ikegami H; Sakai T; Doi K
Exp Toxicol Pathol; 1997 Feb; 49(1-2):39-46. PubMed ID: 9085072
[TBL] [Abstract][Full Text] [Related]
5. Prevention of acetaminophen (APAP)-induced hepatotoxicity by leflunomide via inhibition of APAP biotransformation to N-acetyl-p-benzoquinone imine.
Tan SC; New LS; Chan EC
Toxicol Lett; 2008 Aug; 180(3):174-81. PubMed ID: 18588957
[TBL] [Abstract][Full Text] [Related]
6. Role of CYP3A and CYP2E1 in alcohol-mediated increases in acetaminophen hepatotoxicity: comparison of wild-type and Cyp2e1(-/-) mice.
Wolf KK; Wood SG; Allard JL; Hunt JA; Gorman N; Walton-Strong BW; Szakacs JG; Duan SX; Hao Q; Court MH; von Moltke LL; Greenblatt DJ; Kostrubsky V; Jeffery EH; Wrighton SA; Gonzalez FJ; Sinclair PR; Sinclair JF
Drug Metab Dispos; 2007 Jul; 35(7):1223-31. PubMed ID: 17392391
[TBL] [Abstract][Full Text] [Related]
7. Resistance to acetaminophen-induced hepatotoxicity in glutathione S-transferase Mu 1-null mice.
Arakawa S; Maejima T; Fujimoto K; Yamaguchi T; Yagi M; Sugiura T; Atsumi R; Yamazoe Y
J Toxicol Sci; 2012; 37(3):595-605. PubMed ID: 22687999
[TBL] [Abstract][Full Text] [Related]
8. Role of CYP1A2 in the hepatotoxicity of acetaminophen: investigations using Cyp1a2 null mice.
Tonge RP; Kelly EJ; Bruschi SA; Kalhorn T; Eaton DL; Nebert DW; Nelson SD
Toxicol Appl Pharmacol; 1998 Nov; 153(1):102-8. PubMed ID: 9875304
[TBL] [Abstract][Full Text] [Related]
9. Enhanced nephrotoxicity of acetaminophen in fructose-induced hypertriglyceridemic rats: contribution of oxidation and deacetylation of acetaminophen to an enhancement of nephrotoxicity.
Ishida K; Ikegami H; Doi K
Exp Toxicol Pathol; 1997 Dec; 49(5):313-9. PubMed ID: 9455675
[TBL] [Abstract][Full Text] [Related]
10. Acetaminophen reactive intermediates target hepatic thioredoxin reductase.
Jan YH; Heck DE; Dragomir AC; Gardner CR; Laskin DL; Laskin JD
Chem Res Toxicol; 2014 May; 27(5):882-94. PubMed ID: 24661219
[TBL] [Abstract][Full Text] [Related]
11. Acetaminophen-induced liver injury in obesity and nonalcoholic fatty liver disease.
Michaut A; Moreau C; Robin MA; Fromenty B
Liver Int; 2014 Aug; 34(7):e171-9. PubMed ID: 24575957
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of diallyl sulfone against acetaminophen-induced hepatotoxicity in mice.
Lin MC; Wang EJ; Patten C; Lee MJ; Xiao F; Reuhl KR; Yang CS
J Biochem Toxicol; 1996; 11(1):11-20. PubMed ID: 8806047
[TBL] [Abstract][Full Text] [Related]
13. Effects of fructose-induced hypertriglyceridemia on hepatorenal toxicity of acetaminophen in rats: role of pharmacokinetics and metabolism of acetaminophen.
Ishida K; Sakazume M; Watanabe M; Hirai N; Ikegami H; Sakai T; Doi K
Exp Toxicol Pathol; 1997 Aug; 49(3-4):207-15. PubMed ID: 9314055
[TBL] [Abstract][Full Text] [Related]
14. Alteration in metabolism and toxicity of acetaminophen upon repeated administration in rats.
Kim SJ; Lee MY; Kwon DY; Kim SY; Kim YC
J Pharmacol Sci; 2009 Oct; 111(2):175-81. PubMed ID: 19834287
[TBL] [Abstract][Full Text] [Related]
15. Isatidis Folium alleviates acetaminophen-induced liver injury in mice by enhancing the endogenous antioxidant system.
Ding CH; Zhu H
Environ Toxicol; 2020 Nov; 35(11):1251-1259. PubMed ID: 32677766
[TBL] [Abstract][Full Text] [Related]
16. A monkey model of acetaminophen-induced hepatotoxicity; phenotypic similarity to human.
Tamai S; Iguchi T; Niino N; Mikamoto K; Sakurai K; Sayama A; Shimoda H; Takasaki W; Mori K
J Toxicol Sci; 2017; 42(1):73-84. PubMed ID: 28070111
[TBL] [Abstract][Full Text] [Related]
17. Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice.
Zaher H; Buters JT; Ward JM; Bruno MK; Lucas AM; Stern ST; Cohen SD; Gonzalez FJ
Toxicol Appl Pharmacol; 1998 Sep; 152(1):193-9. PubMed ID: 9772215
[TBL] [Abstract][Full Text] [Related]
18. A 1H NMR-based metabolomics approach for mechanistic insight into acetaminophen-induced hepatotoxicity.
Fukuhara K; Ohno A; Ando Y; Yamoto T; Okuda H
Drug Metab Pharmacokinet; 2011; 26(4):399-406. PubMed ID: 21670543
[TBL] [Abstract][Full Text] [Related]
19. An indole derivative protects against acetaminophen-induced liver injury by directly binding to N-acetyl-p-benzoquinone imine in mice.
Park JH; Seo KS; Tadi S; Ahn BH; Lee JU; Heo JY; Han J; Song MS; Kim SH; Yim YH; Choi HS; Shong M; Kweon G
Antioxid Redox Signal; 2013 May; 18(14):1713-22. PubMed ID: 23121402
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic metabolite of acetaminophen, N-acetyl-p-benzoquinone imine, produces cataract in DBA2 mice.
Qian W; Amin RH; Shichi H
J Ocul Pharmacol Ther; 1999 Dec; 15(6):537-45. PubMed ID: 10609776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
